General Proximity

Emerging

Company Overview

General Proximity is a biotechnology company pioneering induced proximity medicines that work by bringing together disease-causing proteins to trigger their degradation or modulation, representing a new therapeutic modality beyond traditional small molecules and biologics. Founded in 2020 and backed by Y Combinator (W20), the company raised $16M in Series A funding in January 2025 led by Tomales Bay Capital. General Proximity's platform combines computational chemistry, medicinal chemistry, and structural biology to design molecular glues and PROTACs (proteolysis-targeting chimeras) for previously undruggable targets in oncology and other disease areas.

Revenue
$16M
Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

General Proximity is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

AI Visibility Rankings

How General Proximity performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for General Proximity

See exactly how General Proximity ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Compare with Other Brands

See how General Proximity stacks up against competitors with our detailed comparison tool.

Start Comparison